Abstract
A total of 76 clinical Mycobacterium tuberculosis isolates from Taiwan were tested for pyrazinamidase activity, pyrazinamide susceptibility, and pncA mutations. Frequency of resistance to PZA rose with increases in resistance to first-line drugs. Of 17 pyrazinamide-resistant strains, 7 (3 of which had not been previously described) possessed mutations in the pncA gene.
Original language | English |
---|---|
Pages (from-to) | 3672-3673 |
Number of pages | 2 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 47 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2003 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
- Pharmacology